301393.SZ
昊帆生物
SZSE · C 制造业 · CN
CNY 61.32
−6.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 57.76x
- PEG TTM
- 3.21x
- Price / book
- 2.81x
- Price / sales
- 9.42x
- Price / cash flow
- 43.05x
Enterprise value
- Enterprise value
- CNY 5.6B
- EV / sales
- 8.73x
- EV / EBITDA
- 30.86x
- EV / EBIT
- 39.39x
- Market cap
- CNY 6.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026